-
1
-
-
13844255273
-
Molecular biology and genetics of Alzheimer's disease
-
St George-Hyslop PH, Petit A (2004). Mo-lecular biology and genetics of Alzheimer's disease. C R Biol, 328: 119-30.
-
(2004)
C R Biol
, vol.328
, pp. 119-130
-
-
St George-Hyslop, P.H.1
Petit, A.2
-
2
-
-
2542458419
-
Chasing genes in Alzheimer's and Parkinson's disease
-
Bertoli-Avella AM, Oostra BA, Heutink P (2004). Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet, 114: 413-38.
-
(2004)
Hum Genet
, vol.114
, pp. 413-438
-
-
Bertoli-Avella, A.M.1
Oostra, B.A.2
Heutink, P.3
-
3
-
-
4644295495
-
Deficiency of ABCA1 impairs Apo-lipoprotein E Metabolism in Brain
-
Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, et al. (2004). Deficiency of ABCA1 impairs Apo-lipoprotein E metabolism in brain. J Biol Chem, 279: 41197-207.
-
(2004)
J Biol Chem
, vol.279
, pp. 41197-41207
-
-
Hirsch-Reinshagen, V.1
Zhou, S.2
Burgess, B.L.3
Bernier, L.4
McIsaac, S.A.5
Chan, J.Y.6
-
4
-
-
42249103252
-
Fatty ac-ids, lipid metabolism and Alzheimer pathology
-
Hooijmans CR, Kiliaan AJ (2008). Fatty ac-ids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol, 585: 176-96.
-
(2008)
Eur J Pharmacol
, vol.585
, pp. 176-196
-
-
Hooijmans, C.R.1
Kiliaan, A.J.2
-
5
-
-
4644361588
-
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of as-trocyte-secreted apoE
-
Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, et al. (2004). ABCA1 is required for normal central nervous system ApoE levels and for lipidation of as-trocyte-secreted apoE. J Biol Chem, 279: 40987-93.
-
(2004)
J Biol Chem
, vol.279
, pp. 40987-40993
-
-
Wahrle, S.E.1
Jiang, H.2
Parsadanian, M.3
Legleiter, J.4
Han, X.5
Fryer, J.D.6
-
7
-
-
9144229429
-
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E Expression, Secretion and Cholesterol Homeostasis In As-trocytes
-
Liang Y, Lin S, P.Beyer T, Zhang Y, Wu X, Bales KR, et al. (2004). A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in as-trocytes. J Neurochem, 88: 623-34.
-
(2004)
J Neurochem
, vol.88
, pp. 623-634
-
-
Liang, Y.1
Lin, S.2
Beyer, P.T.3
Zhang, Y.4
Wu, X.5
Bales, K.R.6
-
8
-
-
12344319293
-
Association between apolipopro-tein E Polymorphism and Alzheimer Disease in Tehran, Iran
-
Vaisi Raygani A, Zahraia M, Vaisi Raygani A, Doostia M, Javadic E, Rezaeid M, et al. (2005). Association between apolipopro-tein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett, 375: 1-6.
-
(2005)
Neurosci Lett
, vol.375
, pp. 1-6
-
-
Vaisi, R.A.1
Zahraia, M.2
Vaisi, R.A.3
Doostia, M.4
Javadic, E.5
Rezaeid, M.6
-
9
-
-
0027327267
-
Association of Apoliprotein E Allele E4 With the Late-onset Familial and Sporadic Alzheimer Disease
-
Saunders A, Strittmatter WJ, Schmechel S, George-Hyslop PS, Pericak-Vance M, Joo SH, et al. (1993). Association of Apoliprotein E allele e4 with the late-onset familial and sporadic Alzheimer disease. Neurology, 43: 1467-72.
-
(1993)
Neurology
, vol.43
, pp. 1467-1472
-
-
Saunders, A.1
Strittmatter, W.J.2
Schmechel, S.3
George-Hyslop, P.S.4
Pericak-Vance, M.5
Joo, S.H.6
-
10
-
-
0027194791
-
Gene dose of Apolipoprotein E Type 4 Allele and The Risk For Alzheimer's Disease In Late Onset Families
-
Corder EH, Saunders AM, Srittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. (1993). Gene dose of Apolipoprotein E type 4 allele and the risk for Alzheimer's disease in late onset families. Science, 261: 921-23.
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Srittmatter, W.J.3
Schmechel, D.E.4
Gaskell, P.C.5
Small, G.W.6
-
11
-
-
0028816355
-
Apolipoprotein E and Alzheimer's Disease: Ethnic Variation In Genotype Risks
-
Maestre G, Ottman R, Stern Y, Mayeux R (1995). Apolipoprotein E and Alzheimer's disease: ethnic variation in genotype risks. Ann Neurol, 37: 254-59.
-
(1995)
Ann Neurol
, vol.37
, pp. 254-259
-
-
Maestre, G.1
Ottman, R.2
Stern, Y.3
Mayeux, R.4
-
12
-
-
0025801744
-
Apolipoprotein E Genotyping By One-stage PCR
-
Wenham PR, Price WH, Blundell G (1991). Apolipoprotein E genotyping by one-stage PCR. The Lancet, 337:1158-9.
-
(1991)
The Lancet
, vol.337
, pp. 1158-1159
-
-
Wenham, P.R.1
Price, W.H.2
Blundell, G.3
-
13
-
-
0028305380
-
Protective effect of apolipoprotein E Type 2 Allele For Late Onset Alzheimer Disease
-
Corder EH, Saunders AM, Risch NJ (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet, 7: 180-84.
-
(1994)
Nat Genet
, vol.7
, pp. 180-184
-
-
Corder, E.H.1
Saunders, A.M.2
Risch, N.J.3
-
14
-
-
0030612492
-
Apolipoprotein E ε2 Does Not Increase Risk of Early-onset Sporadic Alzheimer's Disease
-
Scott WK, Saunders AM, Gaskell PC, Locke PA, Growdon JH, Farrer LA, et al. (1997). Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease. Ann Neurol, 42: 376-78.
-
(1997)
Ann Neurol
, vol.42
, pp. 376-378
-
-
Scott, W.K.1
Saunders, A.M.2
Gaskell, P.C.3
Locke, P.A.4
Growdon, J.H.5
Farrer, L.A.6
-
15
-
-
0033647304
-
Identification of novel genes in late-onset Alzheimer's disease
-
Pericak-Vancea MA, Grubbera J, Baileyb LR, Hedgesa D, Westa S, Santoroa L, et al. (2000). Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol, 35: 1343-52.
-
(2000)
Exp Gerontol
, vol.35
, pp. 1343-1352
-
-
Pericak-Vancea, M.A.1
Grubbera, J.2
Baileyb, L.R.3
Hedgesa, D.4
Westa, S.5
Santoroa, L.6
-
16
-
-
4243215848
-
Apolipoprotein E Isoform-dependent Amyloid Deposition and Neuritic Degeneration in a Mouse Model of Alzheimer's Disease
-
Holtzman DM, Bales KR, Tenkovai T, Fagan AM, Parsadanian M, Sartorius LJ, et al. (2000). Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA, 97: 2892-97.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 2892-2897
-
-
Holtzman, D.M.1
Bales, K.R.2
Tenkovai, T.3
Fagan, A.M.4
Parsadanian, M.5
Sartorius, L.J.6
-
17
-
-
0027936599
-
Apolipoprotein E Allele Epsilon 4 is Linked to Increased Deposition of The Amyloid Beta-peptide (A-beta) In Cases With Or Without Alzheimer's Disease
-
Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P (1994). Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett, 178: 221-24.
-
(1994)
Neurosci Lett
, vol.178
, pp. 221-224
-
-
Berr, C.1
Hauw, J.J.2
Delaere, P.3
Duyckaerts, C.4
Amouyel, P.5
-
18
-
-
0030050286
-
Clinical and pathological correlates of apol-ipoprotein E Epsilon 4 In Alzheimer's Disease
-
Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, et al. (1996). Clinical and pathological correlates of apol-ipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol, 39: 62-70.
-
(1996)
Ann Neurol
, vol.39
, pp. 62-70
-
-
Gomez-Isla, T.1
West, H.L.2
Rebeck, G.W.3
Harr, S.D.4
Growdon, J.H.5
Locascio, J.J.6
-
19
-
-
0032492113
-
Alzheimer Diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases
-
Roses AD (1998). Alzheimer Diseases: A model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet, 81: 49-57.
-
(1998)
Am J Med Genet
, vol.81
, pp. 49-57
-
-
Roses, A.D.1
-
20
-
-
0035826546
-
Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls
-
Perry RT, Collins JS, Harrell, Acton RT, Go RC (2001). Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet, 105: 332-42.
-
(2001)
Am J Med Genet
, vol.105
, pp. 332-342
-
-
Perry, R.T.1
Collins, J.S.2
Harrell, A.R.T.3
Go, R.C.4
|